Mahesh K. Puri

发表

Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania.

J. Clemens, A. Khatib, B. Ley, 2010, Bulletin of the World Health Organization.

Schools as potential vaccination venue for vaccines outside regular EPI schedule: results from a school census in Pakistan

Z. Bhutta, I. Haq, J. Clemens, 2012, BMC Research Notes.

Using a fingerprint recognition system in a vaccine trial to avoid misclassification

Anna Lena Lopez, Lorenz von Seidlein, Mohammad Ali, 2007 .

Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial

Allan Donner, Anna Lena Lopez, Jan Holmgren, 2011, PLoS neglected tropical diseases.

The Burden of Invasive Bacterial Infections in Pemba, Zanzibar

B. Ley, J. Clemens, K. Thriemer, 2012, PloS one.

Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan.

Z. Bhutta, Z. Bhutta, R. Sack, 2012, Journal of infection in developing countries.

An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India

H. Khuntia, A. S. Kerketta, S. Kar, 2015, PLoS neglected tropical diseases.

Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial.

A. K. Maheshwari, Z. Bhutta, C. Acosta, 2006, Bulletin of the World Health Organization.

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

Allan Donner, Anna Lena Lopez, Jan Holmgren, 2009, The Lancet.

Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India

H. Khuntia, L. Kaljee, A. S. Kerketta, 2014, Human vaccines & immunotherapeutics.

Correction: Risk Map of Cholera Infection for Vaccine Deployment: The Eastern Kolkata Case

M. Convertino, G. Nair, J. Clemens, 2013, PLoS ONE.

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Allan Donner, Anna Lena Lopez, Thomas F Wierzba, 2013, The Lancet. Infectious diseases.

A multi‐country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design

A. Donner, T. Pang, C. Acosta, 2005, Tropical medicine & international health : TM & IH.

Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique.

J. Clemens, P. Guérin, Mohammad Ali, 2006, Vaccine.

Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania.

L. Kaljee, J. Clemens, B. Ley, 2013, Vaccine.

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

A. Donner, C. Acosta, N. Ganguly, 2009, The New England journal of medicine.

Risk Map of Cholera Infection for Vaccine Deployment: The Eastern Kolkata Case

Matteo Convertino, Anna Lena Lopez, Mohammad Ali, 2013, PloS one.

Pandemic Serovars (O3:K6 and O4:K68) of Vibrio parahaemolyticus Associated with Diarrhea in Mozambique: Spread of the Pandemic into the African Continent

D. Sack, G. Nair, A. Safa, 2005, Journal of Clinical Microbiology.

Effectiveness of mass oral cholera vaccination in Beira, Mozambique.

J. Clemens, L. Seidlein, P. Guérin, 2005, The New England journal of medicine.

Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

G. Nair, H. Khuntia, A. S. Kerketta, 2014, PLoS neglected tropical diseases.

25 Years after Vi Typhoid Vaccine Efficacy Study, Typhoid Affects Significant Number of Population in Nepal

T. Wierzba, R. L. Ochiai, D. Bajracharya, 2014, PloS one.

Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population

Taesung Park, Lorenz von Seidlein, Jacqueline L Deen, 2006, BMC infectious diseases.

Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]

A. Donner, Z. Bhutta, T. Pang, 2006, Trials.

Utilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever.

L. Kaljee, J. Clemens, B. Ley, 2013, The American journal of tropical medicine and hygiene.

Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan.

Z. Bhutta, J. Clemens, S. Soofi, 2015, Vaccine.

Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.

A. Donner, G. Nair, J. Clemens, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

5 year effi cacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata , India : a cluster-randomised , double-blind , placebo-controlled trial

A. Donner, S. Niyogi, J. Clemens, 2013 .

Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, Zanzibar

Benedikt Ley, Thomas F Wierzba, Kamala Thriemer, 2012, BMC Research Notes.

Is HIV infection associated with an increased risk for cholera? Findings from a case–control study in Mozambique

J. Clemens, M. Ansaruzzaman, M. Lucas, 2008, Tropical medicine & international health : TM & IH.

Clinical and Epidemiological Features of Typhoid Fever in Pemba, Zanzibar: Assessment of the Performance of the WHO Case Definitions

B. Ley, J. Clemens, K. Thriemer, 2012, PloS one.

Implementation of good clinical practice guidelines in vaccine trials in developing countries.

Z. Bhutta, T. Pang, C. Acosta, 2007, Vaccine.